Anika Therapeutics

Price & Volume

Stats

See more
52W Range
$16-$29.11
Market Cap
$255.2M
Shares Short
484,377

Financials

See more
Revenue (12 Mos)
$164.1M
Revenue Growth (YoY)
-6.5%
Gross Profit (12 Mos)
$96.7M
Diluted EPS
-$6.64

About

CEO
Dr. Cheryl Renee Blanchard Ph.D.
CFO
Mr. Stephen D. Griffin
Address
32 Wiggins Avenue, Bedford, MA, United States, 01730
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
357